【概要描述】On the morning of April 14, 23, Xu Jian, a first-level researcher of Shenzhen Market Supervision Administration and the person in charge of the special class of biomedical industry planning, Liu Wenliang, vice president of Shenzhen Institute of Drug Control, and Cai Qiaowu, executive vice president and secretary general of Shenzhen Medical Device Industry Association, came to our company to carry out research and exchange work.

News Overview

On the morning of April 14, 2023, Xu Jian, a first-level investigator of the Shenzhen Market Supervision Administration and the head of the city's biopharmaceutical industry planning team, Liu Wenliang, deputy director of the Shenzhen Drug Inspection Research Institute, and Cai Qiaowu, executive vice president and secretary general of the Shenzhen Medical Device Industry Association, visited our company for research and exchange.

Visit Scene

During the meeting, Dr. Sun Yang, the founder of our company, warmly welcomed the research team and gave a detailed introduction to the company's overview, team, and products. Yao, our production manager, introduced the overview of the production line of related products to the research team and explained the company's founding philosophy, research and development products, and corporate vision during the visit.

Xu Jian, the research team member, listened attentively to the presentation and had a question-and-answer exchange with the founder team about the company's research and development achievements. Director Liu Wenliang emphasized in his speech that the city's drug inspection institute currently has abundant animal and scientific research personnel resources. He hopes to actively connect with relevant departments and personnel of the drug inspection institute, make reasonable use of the resource advantages of the drug inspection institute, and promote the development and strength of Lixin Science. Secretary General Cai Qiaowu expressed that Lixin Science has made rapid progress in solving domestic raw material bottlenecks in recent years. He hopes to make reasonable use of the resource advantages of government units and association platforms for continuous innovative development.

This visit further indicates the attention and recognition of our company by relevant government departments and medical organizations. We will continue to adhere to independent research, actively cooperate and exchange with various departments, and contribute to the innovative development of the medical industry in our country with scientific achievements.